These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9350394)

  • 21. The pharmacodynamics and pharmacokinetics of the 5HT1B/1D-agonist zolmitriptan in healthy young and elderly men and women.
    Peck RW; Seaber EJ; Dixon RM; Layton GR; Weatherley BC; Jackson SH; Rolan PE; Posner J
    Clin Pharmacol Ther; 1998 Mar; 63(3):342-53. PubMed ID: 9542478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zolmitriptan.
    Can Fam Physician; 1999 Jun; 45():1491-4, 1497-501. PubMed ID: 10386213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the human basilar artery contractile response to 5-HT and triptans.
    Silva SA; Marques FB; Fontes Ribeiro CA
    Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.
    de Hoon JN; Willigers JM; Troost J; Struijker-Boudier HA; Van Bortel LM
    Clin Pharmacol Ther; 2000 Oct; 68(4):418-26. PubMed ID: 11061582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs.
    Roon KI; Sándor PS; Schoonman GG; Lamers FP; Schoenen J; Ferrari MD; van Dijk JG
    Cephalalgia; 1999 Dec; 19(10):880-5. PubMed ID: 10668107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring event-related potentials.
    Dixon R
    Cephalalgia; 1999 Jul; 19 Suppl 24():29-30; discussion 30-1. PubMed ID: 10526680
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design.
    Geraud G; Olesen J; Pfaffenrath V; Tfelt-Hansen P; Zupping R; Diener HC; Sweet R
    Cephalalgia; 2000 Feb; 20(1):30-8. PubMed ID: 10817444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptans attenuate circadian responses to light.
    Basu P; Ie N; Wensel AL; Baskerville JD; Smith VM; Antle MC
    Eur J Neurosci; 2015 Oct; 42(7):2489-95. PubMed ID: 26228801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90).
    Peck RW; Seaber EJ; Dixon R; Gillotin CG; Weatherley BC; Layton G; Posner J
    Br J Clin Pharmacol; 1997 Dec; 44(6):595-9. PubMed ID: 9431839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy.
    Schoenen J; Sawyer J
    Cephalalgia; 1997 Oct; 17 Suppl 18():28-40. PubMed ID: 9399015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans.
    Moeller FG; Bjork JM; Dougherty DM; Van de Kar LD; Marsh DM; Swann AC
    Psychoneuroendocrinology; 2000 Aug; 25(6):607-18. PubMed ID: 10840172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of zolmitriptan (Zomig) on central serotonergic neurotransmission as assessed by active oddball auditory event-related potentials in volunteers without migraine.
    Hughes AM; Dixon R; Dane A; Kemp J; Cummings L; Yates RA
    Cephalalgia; 1999 Mar; 19(2):100-6; discussion 73. PubMed ID: 10214535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptans reduce the inflammatory response in bacterial meningitis.
    Hoffmann O; Keilwerth N; Bille MB; Reuter U; Angstwurm K; Schumann RR; Dirnagl U; Weber JR
    J Cereb Blood Flow Metab; 2002 Aug; 22(8):988-96. PubMed ID: 12172384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism of action of zolmitriptan].
    Pascual J
    Neurologia; 1998 Oct; 13 Suppl 2():9-15. PubMed ID: 9859690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A triptan too far?
    Meijler W
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):121; author reply 122. PubMed ID: 9886478
    [No Abstract]   [Full Text] [Related]  

  • 36. A triptan too far?
    van der Kuy PH; Lohman JJ
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):121; author reply 122. PubMed ID: 9886477
    [No Abstract]   [Full Text] [Related]  

  • 37. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract]   [Full Text] [Related]  

  • 38. Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteers.
    Smith DA; Cleary EW; Watkins S; Huffman CS; Polvino WJ
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):301-5. PubMed ID: 9660035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Would any acute treatment for migraine demonstrate recurrence?
    Dahlöf C
    Cephalalgia; 1997 Jun; 17 Suppl 17():17-9; discussion 19-20. PubMed ID: 9218881
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats.
    Reuter U; Salomone S; Ickenstein GW; Waeber C
    Cephalalgia; 2004 May; 24(5):398-407. PubMed ID: 15096229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.